iShares U.S. Pharmaceuticals ETF (IHE)
NYSEARCA: IHE · Real-Time Price · USD
69.67
+0.57 (0.82%)
At close: Aug 15, 2025, 4:00 PM
69.67
0.00 (0.00%)
After-hours: Aug 15, 2025, 8:00 PM EDT
IHE Holdings Information
IHE is an equity ETF with a total of 40 individual holdings. The top holdings are Johnson & Johnson stock at 24.60%, Eli Lilly and Company at 18.50%, Viatris at 5.20%, Royalty Pharma at 4.69%, and Merck & Co. at 4.51%.
Total Holdings
40
Top 10 Percentage
77.88%
Asset Class
Equity
ETF Category
Health
Assets
561.34M
PE Ratio
18.02
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | JNJ | Johnson & Johnson | 24.60% |
| 2 | LLY | Eli Lilly and Company | 18.50% |
| 3 | VTRS | Viatris Inc. | 5.20% |
| 4 | RPRX | Royalty Pharma plc | 4.69% |
| 5 | MRK | Merck & Co., Inc. | 4.51% |
| 6 | PFE | Pfizer Inc. | 4.48% |
| 7 | ELAN | Elanco Animal Health Incorporated | 4.27% |
| 8 | BMY | Bristol-Myers Squibb Company | 4.17% |
| 9 | ZTS | Zoetis Inc. | 4.02% |
| 10 | JAZZ | Jazz Pharmaceuticals plc | 3.43% |
| 11 | CORT | Corcept Therapeutics Incorporated | 3.24% |
| 12 | AXSM | Axsome Therapeutics, Inc. | 2.15% |
| 13 | PBH | Prestige Consumer Healthcare Inc. | 1.52% |
| 14 | PRGO | Perrigo Company plc | 1.51% |
| 15 | LGND | Ligand Pharmaceuticals Incorporated | 1.42% |
| 16 | OGN | Organon & Co. | 1.17% |
| 17 | SUPN | Supernus Pharmaceuticals, Inc. | 1.13% |
| 18 | TARS | Tarsus Pharmaceuticals, Inc. | 0.99% |
| 19 | OCUL | Ocular Therapeutix, Inc. | 0.78% |
| 20 | ANIP | ANI Pharmaceuticals, Inc. | 0.73% |
| 21 | AMRX | Amneal Pharmaceuticals, Inc. | 0.67% |
| 22 | HRMY | Harmony Biosciences Holdings, Inc. | 0.67% |
| 23 | HROW | Harrow, Inc. | 0.60% |
| 24 | LQDA | Liquidia Corporation | 0.60% |
| 25 | COLL | Collegium Pharmaceutical, Inc. | 0.57% |
As of Aug 14, 2025